Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Autologous immunosuppressive regulatory B cells show promise in autoimmune disease therapy in vivo

Sep. 7, 2009

Anti-inflammatory CCR2 antagonists with improved pharmacokinetics identified by GlaxoSmithKline

Sep. 3, 2009

Novel ZAP-70 inhibitors reported to be in early development at Cellzome

Aug. 31, 2009

Bayer Schering Pharma identifies novel compounds acting on Toll-like receptors

Aug. 26, 2009

GSK presents preclinical data on novel S1P1 agonist, PPI-4955, at recent ACS meeting

Aug. 26, 2009

Cel-Sci expands flu virus research program

Aug. 21, 2009

S1P1 receptor agonists in development at GSK

Aug. 13, 2009

Selective A2A receptor agonists claimed by PGxHealth for autoimmune conditions

Aug. 12, 2009

PI3K inhibitors presented by UCB for inflammatory and autoimmune diseases

Aug. 12, 2009

FDA grants orphan drug designation to DOR's orBec for chronic gastrointestinal GVHD

Aug. 6, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...